FARE - Food Allergy Research & Education Logo

The Effect of Early Childhood Cow's Milk Allergy Elimination Diet on Eating Behaviors, Nutrition, and Growth Status

Study Purpose

Cow's milk allergy (CMA) is the most common Food Allergy (FA) in children, and the essential strategy in prevention is avoiding the allergens that may cause potentially life-threatening reactions. The primary developmental task of early childhood is the creation of healthy eating habits. The diagnosis of FA in this period can lead to permanent changes in the life of the child and her family. In early childhood, parents are often responsible for all aspects of FA management because children are too young to understand the complexity of avoiding allergens. Children often do not have the skills to implement FA management. Parents are advised to follow a special weaning diet, avoiding any type of cow's milk, usually at least 1 year old. However, depending on the clinical improvement, it can be recommended to continue this exclusion diet for much longer. Thus, many children have to exclude a large group of food from their diets, which is critical for their growth, development, and eating habits. This may raise mealtime behavioral anxiety in a child with a FA. Eating behavioral anxieties are also very common in healthy, typically developing children. Even 25% to 45% of normally developing children's parents report concerns about their child's nutritional and mealtime behaviors, including the destructive child behaviors (eg., refusal of foods, food selectivity, and getting off the table). In children with food allergies, monitoring long-term growth after the diet is another important issue. Growth problems were reported in 21% of children with FA diagnosed with malnutrition. Most studies focused on the effect of changes in eating behavior on growth during an elimination diet or in short term intervals. Its long-term effects have only been analyzed in a few studies. We aimed to investigate the eating behaviors, nutritional status, and growth of young children (ages of 2 to 6) who had a strict diet due to CMA in early childhood (ages of 0-2).

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Unknown
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 2 Years - 6 Years
Gender All
More Inclusion & Exclusion Criteria

The inclusion criteria to the study group will be as follows; 1. to undergo a Cow's milk elimination (CME) diet or took a hypoallergenic formula in 0-2 years of age for at least 3 months or longer due to CMA allergy. 2. improvement of CMA after receiving CME diet, 3. to eliminate other nutrients (e.g., eggs, potatoes, wheat flour, soybean, etc.) other than cow's milk between the ages of 0-2 for at least 3 months or longer, 4. to add other nutrients (as mentioned in criterion 3) back to their diet in the last 3 months, 5. not receiving hypoallergenic formula for the last 3 months, 6. not to be on the CME diet at present. The exclusion criteria from enrollment to the study will be as follows; 1. Children with any disease that may affect eating behavior, nutritional status, and growth. 2. The children with a diagnosis of a disease mentioned below will be excluded from the study. 1. Children with a diagnosis of chronic infection / inflammatory diseases, 2. cystic fibrosis, 3. congenital heart disease, 4. chronic kidney failure, 5. diabetes, 6. gastroesophageal reflux, 7. dysfunction of swallowing, 8. anatomical, cognitive and/or impairment of speech, 9. autoimmune diseases (SLE, RA, thyroid, etc.), 10. congenital genetic diseases, 11. immune deficiency, 12. autism, 13. attention deficit hyperactivity, 14. manic-depressive disorders.

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04576845
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Saglik Bilimleri Universitesi
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

N/A
Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Not yet recruiting
Countries Turkey
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Nutrient Deficiency, Eating Behavior, Cow Milk Allergy, Growth Disorders
Additional Details

Study Design The study is planned to be a cross-sectional, case-control study and it will be carried out between October 2020 and November 2020 in our tertiary care center (university hospital located in Ankara, Turkey). The study will be conducted with the collaboration of the departments of Pediatric Immunology and Allergy and Nutrition and Dietetics. The study was approved by our University ethics committee (2011- KAEK-19) with the decision number of 108/2019. The children eligible for the study group will be enrolled from the pediatric allergy and immunology outpatient unit. The control group children will be selected from the health visitor clinics of Pediatrics. The patient informed consent form will be obtained from all children's parents at the beginning of the study.The study will be performed on Caucasian origin children who are among 2 to 6 years of age. The study group will be composed of children (n=31) who had CMA (Ig E-mediated and/or non-Ig E-mediated and/or mixed type) proved with oral food challenge tests in their early childhood (in ages of 0-2). The control group (n=31) will include healthy children who had never been on a diet throughout their lives. No children in the study and control groups will be on a dietary restriction during the study. The inclusion and the exclusion criteria are given in detail at the space for eligibility. Data collection The children's eating behavior will be evaluated with Turkish validated Children's Eating Behavior Questionnaire

  • - (CEBQ) by interviewing mothers face to face.
The CEBQ is a Likert type, parent-report rating scale measuring the variation in eating behavior in children. The CEBQ consists of 35 items comprising eight subscales, each containing 3 to 6 items. Parents were asked to rate their child's eating behavior on a five-point scale (never, rarely, sometimes, often, always; 1-5, respectively). The 8 subscales of CEBQ and their interpretation are: The sub-scales Satiety Responsiveness (SR) (i.e., "My child has a big appetite", 7 items), Slowness in Eating (SE) (i.e., "My child eats slowly", 4 items), Emotional Undereating (EUE) (i.e., "My child eats less when she/he is tired", 4 items), and Food Fussiness (FF) (i.e., "My child refuses new foods at first", 3 items) assess "food avoidance" (i.e., increased internal satiety and avoidance of eating), while the sub-scales Food Responsiveness (FR) (i.e., "My child is always asking for food", 5 items), Enjoyment of Food (EF) (i.e., "My child loves food", 5 items), Desire to Drink (DD) (i.e., "My child is always asking for a drink", 3 items), and Emotional Overeating (EOE) (i.e., "My child eats more when worried", 4 items) assess "food approach" (i.e., high responsiveness to food). Higher scores indicate a stronger display of food approach or food avoidance (except FF) behavior. In the Turkish version of the CEBQ, a lower score for FF means a stronger display for fussy eating. Therefore, while calculating the food avoidance total score, reversed items of FF were summed with SR, SE, and EUE. The food approach total score will be calculated by the summation of FR, EF, DD, and EOE. Another questionnaire that will be conducted with the mothers will be to discuss their socio-demographic characteristics. Three days' food record will be obtained from each mother (2 weekdays and 1 weekend day). On the same days, the food consumed by children at school will be recorded by the teachers, and consumption registration forms will be combined at the end of three days. Portion sizes and volumes will be estimated with a portion size picture book, including 120 photographs of foods, each with 3-5 different portion sizes. In addition, each serves of participants will be confirmed with the pictures taken by the parents that will show the plates of their children before and after each meal. Only the forms accurately registered will be evaluated. BeBiS software version 7.2 will be used to calculate the daily intake of energy, macronutrients, micronutrients, and dairy products. The Nutrition Guide will be assessed the adequacy of children's nutrient intake for Turkey according to age and gender. The same researcher will take the body weights (kg) and height (cm) of the children with the same method, previously described by the World Health Organization (WHO) using the same measuring instruments. Measurements will be performed using the standardized Conformité Européene marked scales and stadiometers [A baby scale (Testut, Paris) will be used for infants weighing <15 kg and an electronic scale (Seca, Hamburg, Germany) will be used for children weighing >15 kg. Seca 213 and infantometer will be used for measuring participants' height]. Scale and stadiometer are routinely calibrated in our hospital according to rules of quality. Body Mass Index (BMI) will be calculated with the formula kg/m2. The anthropometric (height-for-age [HFA], weight-for-age [WFA], and body mass index-for-age [BMI]) measurements will be evaluated according to the Z-score using the WHO ANTHRO program (Version 3.2.2, January 2011) and WHO ANTHRO Plus Software (WHO, 2009b) [Z-score = Patient's value
  • - Average value / Standard Deviation (SD)].
The Z-score (SDS) in the average child by age will be "0". Values between +2 SD and
  • - 2 SD will be considered normal upper and lower limits.
Primarily, we will compare the eating behavior of children who had a strict CME diet due to CMA in early childhood with healthy children. Secondarily, we will evaluate the effects of children's eating behavior on participants' nutritional status and anthropometric measurements.

Arms & Interventions

Arms

: Study Group

The study will be performed on Caucasian origin children who are among 2 to 6 years of age. The study group will be composed of children (n=31) who had CMA (Ig E-mediated and/or non-Ig E-mediated and/or mixed type) proved with oral food challenge tests in their early childhood (in ages of 0-2). The inclusion criteria to the study group will be to undergo a Cow's milk elimination (CME) diet or took a hypoallergenic formula in 0-2 years of age for at least 3 months or longer due to CMA allergy and improved afterward, and/or to eliminate other nutrients (e.g., eggs, potatoes, wheat flour, soybean, etc.) other than cow's milk between the ages of 0-2 for at least 3 months or longer, and/or to add these nutrients back to their diet in the last 3 months, and/or not receiving hypoallergenic formula for the last 3 months, not to be on the CME diet at present. Thus, no children in the study and control groups will be on a dietary restriction during the study.

Interventions

Other: - Survey

The children's eating behavior will be evaluated with Turkish validated Children's Eating Behavior Questionnaire - (CEBQ) by interviewing mothers face to face. The CEBQ is a Likert type, parent-report rating scale measuring the variation in eating behavior in children. The CEBQ consists of 35 items comprising eight subscales, each containing 3 to 6 items. Parents will be asked to rate their child's eating behavior on a five-point scale (never, rarely, sometimes, often, always; 1-5, respectively).

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Gülhane Training and Research Hospital, Ankara, Turkey

Status

Address

Gülhane Training and Research Hospital

Ankara, , 06010

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.